Screener
Azenta AZTA Multiomics — Segment adjusted operating loss
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Azenta in its filing.
Tagged under the XBRL concept azta:OperatingIncomeLossAdjusted.
The source filing: Azenta’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054295
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Nine Months Ended June 30, 2026 | Nine Months Ended June 30, 2025 |
|---|---|---|---|---|
| Adjusted operating income (loss): | ||||
| Sample Management Solutions | $4,944 | $10,737 | $13,035 | $18,318 |
| Multiomics | (348) | (3,958) | (14,777) | (11,801) |
| Segment adjusted operating income (loss) | $4,596 | $6,779 | $(1,742) | $6,517 |
| Amortization of completed technology | 2,082 | 2,068 | 6,017 | 5,876 |
| Amortization of other intangible assets | 3,616 | 4,123 | 10,730 | 12,499 |
| Transformation costs(1) | 272 | 1,542 | 1,913 | 9,771 |
| Restructuring charges | 513 | 754 | 3,078 | 4,765 |
Item 1. Financial Statements
FAQ
- What is Azenta's multiomics — segment adjusted operating loss?
- Azenta (AZTA) reported multiomics — segment adjusted operating loss of -$348K in Q2 2026.
- What does multiomics — segment adjusted operating loss mean?
- A non-GAAP measure representing the operating loss of the Multiomics segment after adjusting for specific items like stock-based compensation, amortization, or restructuring costs. This metric provides a clearer view of the segment's core operational performance by removing non-cash or non-recurring accounting impacts. It is used to evaluate the underlying profitability trajectory of the business unit.
Ask your AI about Azenta's multiomics — segment adjusted operating loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude